CORDIS
EU research results

CORDIS

English EN
A European Platform for Translational Cancer Research

A European Platform for Translational Cancer Research

Objective

Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer research and stressed the need to improve collaboration between basic/preclinical and comprehensive cancer centres (CCCs), institutions in which care and prevention is integrated with research and education. Furthermore, it proposed the creation of a platform of interlinked cancer centres with shared infrastructures and collaborative projects to facilitate rapid advances in knowledge, and their translation into better cancer care.

In response to these challenges and in line with the call, EurocanPlatform will work towards the goal of decreasing cancer mortality by dealing with three main areas of strategic research: prevention, early detection and improved treatments. It will build the necessary resources and know-how for the entire research continuum: basic research, early and late translational research, clinical research, epidemiological research, implementation in care and population based outcome research. There will be a strong focus on discovery-driven translational cancer research in five selected tumours: breast, head-neck, lung, malignant melanoma and pancreatic cancer. Joint structures and programmes for early detection will contribute to optimal treatment, and novel prevention research programmes will integrate prevention activities in clinical cancer centres as well as public prevention. Collaborations will also include molecular pathway-driven clinical research supported by joint structures for omics, biobanking and biomarker validation to support clinical trials aimed at enhancing patient benefits by individualised treatments.

EurocanPlatform is unique in its nature and represents a commitment from cancer centres to join forces and resources in order to fight cancer.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

KAROLINSKA INSTITUTET

Address

Nobels Vag 5
17177 Stockholm

Sweden

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 708 115

Administrative Contact

Maria Von Witting (Ms.)

Participants (27)

Sort alphabetically

Sort by EU Contribution

Expand all

INSTITUT CURIE

France

EU Contribution

€ 541 022

KRAEFTENS BEKAEMPELSE

Denmark

EU Contribution

€ 625 688

OSLO UNIVERSITETSSYKEHUS HF

Norway

EU Contribution

€ 647 900

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

Spain

EU Contribution

€ 197 700

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Italy

EU Contribution

€ 560 300

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Germany

EU Contribution

€ 787 705

INSTITUT GUSTAVE ROUSSY

France

EU Contribution

€ 479 200

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

France

EU Contribution

€ 725 100

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 135 600

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Italy

EU Contribution

€ 144 800

THE CHRISTIE NHS FOUNDATION TRUST

United Kingdom

EU Contribution

€ 105 600

Orszagos Onkologiai Intezet

Hungary

EU Contribution

€ 84 525

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS

Netherlands

EU Contribution

€ 1 869 613

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 310 200

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

EU Contribution

€ 766 700

INSTITUT JULES BORDET

Belgium

EU Contribution

€ 51 600

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 964 456

THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL

United Kingdom

EU Contribution

€ 225 600

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU Contribution

€ 69 600

Fundación Instituto Valenciano de Oncología

Spain

EU Contribution

€ 34 200

"INSTITUTO TUMORI ""GIOVANNI PAOLO II"""

Italy

EU Contribution

€ 66 710

FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON

Spain

EU Contribution

€ 260 333

ecancermedicalscience AG

Switzerland

EU Contribution

€ 307 997

European CanCer Organisation

Belgium

EU Contribution

€ 50 590

GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI

Belgium

EU Contribution

€ 122 200

EUROPEAN CANCER PATIENT COALITION

Belgium

EU Contribution

€ 73 800

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL

Belgium

EU Contribution

€ 81 600

Project information

Grant agreement ID: 260791

Status

Closed project

  • Start date

    1 January 2011

  • End date

    31 December 2016

Funded under:

FP7-HEALTH

  • Overall budget:

    € 15 561 005,72

  • EU contribution

    € 11 998 454

Coordinated by:

KAROLINSKA INSTITUTET

Sweden